Identification of potential new treatment response markers and therapeutic targets using a Gaussian process-based method in lapatinib insensitive breast cancer models.

Santra, Tapesh; Roche, Sandra; Conlon, Neil; O'Donovan, Norma; Crown, John; O'Connor, Robert; Kolch, Walter

Santra, Tapesh; Roche, Sandra; Conlon, Neil; O'Donovan, Norma; Crown, John; O'Connor, Robert; Kolch, Walter.

Afiliação

Santra T; Systems Biology Ireland, University College Dublin, Belfield, Dublin, Ireland.
Roche S; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
Conlon N; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
O'Donovan N; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
Crown J; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
O'Connor R; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Elm Park, Ireland.
Kolch W; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.

PLoS One ; 12(5): e0177058, 2017.

Article em En | MEDLINE | ID: mdl-28481952

Assuntos

Antineoplásicos/uso terapêutico; Neoplasias da Mama/tratamento farmacológico; Quinazolinas/uso terapêutico; Neoplasias da Mama/patologia; Feminino; Humanos; Lapatinib

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinazolinas / Neoplasias da Mama / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Irlanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google